RxSight CFO and COO Sell Portions of Company Stock in Recent Transactions

Chief Financial Officer Mark Wilterding and Chief Operating Officer Ilya Goldshleger of RxSight have executed sales of their company shares. The divestments were filed as routine executive transactions under standard market disclosure protocols.